Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Pi Network's token fell 12% over the last seven days, slipping below $0.13. Analysts see oversold conditions and upco...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
Google Gemini AI has nudged XRP back into the spotlight with a bold price target for 2026. This report breaks down wh...
Workday introduces AI-driven updates to its Adaptive Planning platform to curb spreadsheet chaos in FP&A. The move ta...
A new Fidelity study finds a majority of Americans foresee steep medical bills in retirement, prompting families to s...
Tech investors shifted away from growth plays as inflation data fed rate worries. This article explains why marvell t...
Samsung Electronics is under a developing insider-trading investigation as regulators scrutinize stock moves tied to ...
May data from the NAHB Eye on Housing show input costs for residential construction accelerated, led by energy prices...
Federal safety regulators are recalling more than coffee makers—about 17,600 Kidisle units—after reports of hot liqui...
June volatility is shaking up high-flyers, turning attention to cash-flow winners. One stock stands out as a no-brain...
The U.S. Housing and Urban Development Department unveiled a proposed rule to expand manufactured housing by allowing...